Monster Beverage (MNST)
NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-30
$47.34+2.14%
Close 2026-10-30 · 1-day change
NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-30
Research Workspace
Put MNST beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Maintain profit margins near 34%: Comparison needs review.
View ThesisRevenue growth is accelerating — up about 20% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMonster’s energy drink growth supports the case, though revenue growth slowed in Q2. Revenue grew 20.2% year over year in Q2 FY2026. Adjusted earnings beat estimates that quarter. MNST trades at 21× P/E versus a 16× peer median. Its price reflects less growth than our forecast. The risk is margin pressure, with the annual comparison needing review. Our model puts the next-quarter miss probability near 16%. Peer multiples imply a price about 28% above where it trades. The thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. MNST is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 25 analysts currently covering MNST (as of Oct 2026).
Based on 7 Wall Street analysts offering 12-month price targets for MNST in the last 4 months.
Continue this research
Compare MNST with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MNST Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Soft Drinks & Non-alcoholic Beverages — fair value, gap to price, and forward P/E.
Compare the value case
Put MNST next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Regulatory challenges could impact international sales growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $47.34
The last 12 months of price, then the range of analyst 12-month targets from today’s $47.34.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Loss of key executive may impact innovation and strategy.
Advances: Expand international sales
Strong international results support growth objectives.
Advances: Expand international sales
Earnings beat indicates strong sales growth, supporting international expansion.
Advances: Expand international sales
Surprise sales indicate positive momentum in international markets.
Advances: Expand international sales
International growth aligns with management's expansion objective.
Advances: Expand international sales
Revenue topping estimates suggests effective growth strategy.
Advances: Expand international sales
Sales rise due to international growth supports expansion goals.